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ABSTRACT
The aim of this case report is to demon-
strate that during extensive and long-last-
ing mutilating operations it is necessary 
to use an aggressive volume replacing ap-
proach to maintain adequate tissue oxy-
genation. 
A satisfactory level of tissue oxygenation 
is necessary to uphold the function and 
structure of cells, tissue and organs. Moni-
toring the haemodynamic function during 
the operation is an important task for the 
anaesthesiologist.
We present a case of a 58-year-old woman 
with widespread malignant disease, who 
underwent surgical treatment in our hos-
pital.
The operation was mutilating and long-
lasting. During the perioperative period 
the patient received a large volume of flu-
ids and blood products due to extensive 
intraoperative blood loss. High doses of 
vasoactive drugs were also introduced to 
achieve haemodynamic stability. 
Due to adequate and aggressive volume 
replacement, haemodynamic stability was 
eventually achieved and the outcome was 
beneficial for our patient.
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INTRODUCTION
Adults who lose more than 15% of their 
blood volume usually require blood trans-
fusions to maintain the transmission ca-
pacity of oxygen. Intraoperative blood 
loss is estimated by adding the amount of 
blood in the aspiration bottle, measuring 
the weight of the pads during and after the 
procedure, and estimating the amount of 
blood in the rinse solution. Blood remis-
sion must be adequate; hemoglobin should 
be determined intraoperatively (1).
In this case, report we describe a patient 
with significant hemodynamic instability 
that occurred during the intraoperative 
period due to massive loss of circulating 
blood volume.
Intravenous fluid administration is the 
main therapy that stabilizes the patient 
and reduces the effects of hemorrhagic 
shock (2).
CASE PRESENTATION
A 58-years old female, with a history of di-
abetes, hypertension and hypothyroidism 
was hospitalized for the surgical treatment 
of a recurrent tumor process in the pelvis. 
An eight-hour operation took place. A pel-
vic exenteration was done, with resections 
of the urinary bladder, rectum and uterus 
- which had extensively merged with the 
tumor tissue.
During the perioperative period, the pa-
tient was extremely hemodynamically 
unstable due to extensive blood loss. The 
total volume losses during the operation 
were 13990ml. Out of that amount 9600ml 
was blood, while her estimated circulating 
blood volume was 7000ml. Volume re-
placement was performed with crystalline 
and colloidal solutions, erythrocyte con-
centrate and fresh frozen plasma (Table 1).
Since hemodynamic stability could not 
be achieved solely via volume replace-
ment, vasopressor (norepinephrine) and 
inotrope (epinephrine) infusions were also 
started.
Because the measurements received 
through the arterial cannula in the radial 
artery were inadequate, the measurement 
of arterial pressure was started directly in-
side the aorta. At the end of the operation, 
the aorta artery cannula was removed and 
inserted into the right femoral artery. 
Despite the attempts of hemodynamic sta-
bilization by aggressive blood transfusion 
and large volume solutions, along with the 
continuous infusion of vasopressors and 
inotropes, the patient was highly hemody-
namically unstable (Figure 1).
Due to refractory hemodynamic instabil-
ity, in agreement with the surgeons, the 
surgical procedure was terminated. The 
patient was admitted to the Intensive Care 
Unit. The immediate postoperative course 
yielded further vasopressor support with 
norepinephrine, epinephrine and ter-
lipresine; aggressive infusion replacement 
and replenishment of blood and blood 
derivatives, as well as antifibrinolytics and 
recombinant factor VII. Continuous infu-
sion of epinephrine was discontinued on 
the day of the surgery, and low doses of 
norepinephrine were needed for the next 
two days. Hemodynamic stability was re-
stored on the third postoperative day (Ta-
ble 1).
Renal replacement therapy was initiated 
on day one due to oligo-anuria, uremia 
and metabolic imbalance. On the second 
postoperative day the patient was subject-
ed to a new surgical procedure to complete 
the planned surgical treatment. The opera-
tion was uneventful. 
On the 30th postoperative day the patient 
was transferred to the surgical unit. 
DISCUSSION
Volume replacement is the basis of hemo-
dynamic stabilization in hemorrhagic shock 
(3). Transfusion therapy is a supportive 
part of the treatment of many diseases and 
clinical conditions. It is justified only in cases 
when the lack of blood component cannot 
be compensated by another, alternative way, 
and non-adherence would cause deteriora-
tion of the clinical condition or endanger the 
patient's life (4).
The standard therapeutic procedure during 
volume replacement must achieve the cor-
rection of global hemodynamic blood pres-
sure variables, leading to a variable outcome 
of critically ill patients (5). The variability of 
outcomes is the result of unrecognized shock 
that is masked by the patient's compensating 
mechanisms (6). Poeze et all (7) have shown 
that there is no ideal hemodynamic variable 
that could serve as a predictor of outcome.
In most cases, an accurate diagnosis and 
therapy depend on the precise measurement 
of hemodynamic parameters (8).
Although the pulmonary artery catheter is 
the "gold standard" for hemodynamic moni-
toring, less invasive methods such as PiCCO 
(Pulse Contour Cardiac Output), LIDCO 
(Lithium Dilution Cardiac Output), tran-
sthoracic and transesophageal echocardiog-
raphy are used for hemodynamic monitor-
ing and the assessment of volume status in 
critically ill patients (9).
Furthermore, large blood loss leads to co-
agulopathy. To determine the degree of 
coagulopathy precisely, a thromboelasto-
graph (TEG®) and/or thromboelastomer 
(ROTEM®) should be used. These methods 
provide global information on the dynamics 
of development, stabilization and dissolu-
tion of clots that reflect in vivo hemostasis 
(10). 
None of the aforementioned monitoring was 
available intraoperatively. We estimated the 
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volume replacement by electrocardiogram, 
pulse, invasive arterial pressure, central ve-
nous pressure measurement and laboratory 
findings (complete blood count, acid-base 
status and coagulation parameters). Static 
parameters of hemodynamics were the 
leading source in the decision-making and 
therapy adjustment.
Despite the lack of above mentioned moni-
tors, the patient had a satisfactory postop-
erative outcome and recovered well.
CONCLUSION
In patients undergoing major surgical in-
terventions with large blood losses, it is im-
perative to use aggressive volume replace-
ment in order to achieve adequate tissue 
oxygenation. Large fluid inputs also carry 
a significant danger of potential complica-
tions, so additional hemodynamic monitor-
ing should be employed as early as possible, 
after the resuscitation phase has ceased. 
In our case, the patient responded well to 
our resuscitation measures, so we did not 
expand the monitoring any further. At the 
same time, various methods of surveillance 
are available to the clinician, reducing the 
occurrence of multiple organ dysfunction - 
or its early recognition and treatment. 
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Table 1. Numerical display of volume loss and its replacement
INTRAOPERATIVE 0.DAY 1.DAY
VOLUME LOSSES (ml) 12690 7750 3125 + CVVHFD 600ML
VOLUME REPLACEMENT (ml) Crystalloids 10000 4000 4000
Colloids                                 2500 500 1000
RBC Concentrates                     4040 4310      1880
FFP 2250 3370 --
Cryoprecipitate -- 980 --
Thrombocytes -- 1508 300
Albumins 5% --                                -- 250
TOTAL VOLUME REPLACEMENT (ml) 18790 14668 7430
Continuous norepinephrine infusion (mcg/min) 77 13 19
Continuous epinephrine infusion (mcg/min) 23 -- --
